Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Homatropine and its salts

for ophthalmic or parenteral use or in preparations for oral use containing more than 2 mg per dosage unit

Approval Date:

Schedule: I